OPIANT PHARMACEUTICALS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Opiant Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q3 2022.
  • Opiant Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2022 was $2.74M, a 175% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $2.74M +$1.74M +175% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $733K -$386K -34.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $875K +$728K +498% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $1M +$721K +259% Dec 31, 2021 10-Q 2022-11-14
Q3 2021 $998K +$601K +151% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $1.12M +$611K +120% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $146K -$481K -76.7% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $278K -$490K -63.8% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $397K -$452K -53.3% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $508K Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $628K Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $768K -$432K -36% Dec 31, 2019 10-K 2021-03-04
Q3 2019 $849K Sep 30, 2019 10-Q 2019-11-12
Q4 2018 $1.2M Jan 1, 2019 10-Q 2022-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.